We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

3 hedge funds and large institutions have $40.2M invested in Plus Therapeutics in 2014 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $35.4M → $40.2M (+$4.77M)

0% more funds holding

Funds holding: 33 (0)

84% less call options, than puts

Call options by funds: $70K | Put options by funds: $434K

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$70K
Puts
$434K
Net Calls
-$364K
Net Calls Change
-$31K
Name Holding Trade Value Shares
Change
Change in
Stake
Principal Financial Group
76
Principal Financial Group
Iowa
-$64K
Renaissance Technologies
77
Renaissance Technologies
New York
-$119K
ST
78
Spot Trading
Illinois
-$12K
VKH
79
Virtu KCG Holdings
New York
-$82K
WAM
80
Wolverine Asset Management
Illinois
-$86K

PSTV Hedge Fund Activity: Q1 2014 in Review

3 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2014, worth a combined $40.2M — up 13% from $35.4M a quarter earlier.

Fund positioning in PSTV was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Millennium Management, cutting an estimated $140K.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $40.2M of Plus Therapeutics stock for Q1 2014, up 13% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q1 2014 and 0 closed out.
  • The largest Plus Therapeutics seller in Q1 2014 was Millennium Management, an estimated $140K sold.

Based on aggregated 13F filings for Q1 2014.